[1] Gao M, Shih Ie M, Wang TL. The role of forkhead box Q1 transcription factor in ovarian epithelial carcinomas[J]. Int J Mol Sci,2012,13(11):13881-13893.
[2] Oommen D, Yiannakis D, Jha AN. BRCA1 deficiency increases the sensitivity of ovarian cancer cells to auranofin[J]. Mutat Res, 2016, 784-785(11): 8-15.
[3] Luo BH, Xiong F, Wang JP, et al. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells[J]. PLoS One, 2014, 9(6): e99922.
[4] Ibanez dCI, Battagli C, Esteller M, et al. Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients[J]. Cancer Res, 2004, 64(18): 6476-6481.
[5] Ahmed N, Thompson EW, Quinn MA, Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm[J]. J Cell Physiol, 2007,213(3): 581-588.
[6] Ganan Gomez Ⅰ, Wei Y, Yang H, et al. Oncogenic functions of the transcription factor Nrf2[J]. Free Radic Biol Med, 2013, 65(12): 750-764.
[7] Tsai JJ, Dudakov JA, Takahashi K, et al. Nrf2 regulates haematopoietic stem cell function[J]. Nat Cell Biol, 2013, 15(3): 309-316.
[8] Kumar SM, Dey A. Regulation of glutathione in health and disease with special emphasis on chronic alcoholism and hyperglycaemia mediated liver injury: a brief perspective[J]. Springer Sci Rev, 2014,2(1-2): 1-13.
[9] Kang X, Chen W, Kim RH, et al. Regulation of the hTERT promoter activity by MSH2, the hnRNPs K and D, and GRHL2 in human oral squamous cell carcinoma cells[J]. Oncogene, 2009, 28(4): 565-574.
[10] Xiang X, Deng Z, Zhuang X, et al. Grhl2 determines the epithelial phenotype of breast cancers and promotes tumor progression[J]. PLoS One, 2013, 8(4): 50781.
[11] Kajiwara K, Saito A, Ogata SI, et al. Synthetic peptides corresponding to ligand-binding region of death receptors, DR5, Fas, and TNFR, specifically inhibit cell death mediated by the death ligands, respectively[J]. Biochim Biophys Acta, 2004, 1699(1-2):131-137.
[12] Chen W, Yi JK, Shin KH, et al. Abstract 1598: grainyhead-like 2 (GRHL2) regulates the expression of forkhead box transcription factor M1 (FoxM1) in human oral cancer cells and determines tumorigenicity[J]. Cancer Res, 2014, 74(19 Suppl):1598-1598.
[13] Xiang J, Fu X, Ran W, et al. Grhl2 reduces invasion and migration through inhibition of TGFβ-induced EMT in gastric cancer[J]. Oncogenesis, 2017, 6(1):e284.
[14] Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway.[J]. Annu Rev Pharmacol Toxicol, 2007, 47(1):89-116.
[15] Arif JM, Sawant SS, Sayed KAE, et al. Antiproliferative potential of sarcophine and its semisynthetic sulfur-containing derivatives against human mammary carcinoma cell lines[J]. J Natl Med, 2006, 61(2):154-158.
[16] Chen Z, Shentu TP, Wen L, et al.Regulation of SIRT1 by oxidative stress-responsive miRNAs and a systematic approach to identify its role in the endothelium[J]. Antioxid Redox Signal, 2013, 19(13):1522-1535.
[17] Mooney SM, Talebian Ⅴ, Jolly MK et al. The GRHL2/ZEB feedback loop-a key axis in the regulation of EMT in breast cancer[J]. J Cell Biochem, 2017, 118(9):112-125.
[18] Faddaoui A, Sheta R, Bachvarova M, et al.Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells[J]. Cell Cycle, 2017, 16(7): 693-706.
[19] Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway[J]. Annu Rev Pharmacol Toxicol, 2007, 47(1):89-116.
[20] Jaiswal AK. Nrf2 signaling in coordinated activation of antioxidant gene expression [J]. Free Radic Biol Med, 2004, 36(10):1199-1207.
|